H. Sookdeo

Molecular cloning of murine FLT and FLT4.

D. Merberg, R. Kriz, K. Kelleher, 1993, Oncogene.

Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides

J. Hatzfeld, A. Hatzfeld, E. Brown, 1991, The Journal of experimental medicine.

Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug

P. Dosa, M. Fautsch, B. Wirostko, 2022, Investigative ophthalmology & visual science.

Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults.

J. Hatzfeld, A. Hatzfeld, E. Brown, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Investigation of the 'switch-epitope' concept with random peptide libraries displayed as thioredoxin loop fusions.

J. Mccoy, J M McCoy, Z. Lu, 2001, Protein engineering.

Additive effects of steel factor and antisense TGF-beta 1 oligodeoxynucleotide on CD34+ hematopoietic progenitor cells.

J. Hatzfeld, A. Hatzfeld, E. Brown, 1994, Leukemia.

Alanine‐scanning Mutagenesis of Human Interleulcin‐11: Identification of Regions Important for Biological Activity

J. Mccoy, H. Scoble, Frann Bennett, 1995, Annals of the New York Academy of Sciences.

Autocrine transforming growth factor-β controls G0 phase of early human hematopoietic progenitors in serum- or serum-free culture

J. Hatzfeld, A. Hatzfeld, E. Brown, 1991 .

Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent.

P. Dosa, M. Fautsch, B. Wirostko, 2023, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Autocrine Transforming Growth-Factor-Beta Controls G0 Phase of Early Human Hematopoietic Progenitors in Serum-Free or Serum-Free Culture

J. Hatzfeld, A. Hatzfeld, E. Brown, 1991 .